Still the benchmark

A decade of proven outcomes has established AirFit™ P10 as the standard in nasal pillows masks — and the data keeps confirming it.

Explore AirFit™ P10

Buy now

See the evidence

90%

of patients achieved compliance in just 39 days¹

Early compliance supports long-term therapy success.

#1

choice of HMEs across comfort, seal and durability²

Trusted by the providers who fit and support patients every day.

Nearly 80%

of new users achieved compliance within 90 days³

Consistent outcomes from the very start of therapy.

Rated highest

in brand reputation and trust among HMEs²

A decade of proven performance builds confidence that's difficult to replicate.

Quietest

pillows mask on the market⁴

Fewer disturbances mean fewer barriers to therapy use.

Why providers continue to choose AirFit™ P10

Built for early compliance

Earlier compliance¹ helps patients establish therapy early while giving providers confidence in treatment success.

Less leaks, better therapy

Lower leak rates⁵ help support more consistent therapy,³ giving providers confidence they're making a strong mask choice.

Simple setup for daily use

A streamlined design simplifies setup, fitting and patient onboarding, creating a more efficient experience for both providers and patients.

A quieter therapy experience

A quieter⁴ therapy experience means fewer disturbances for patients and their bed partners.

How AirFit™ P10 delivers performance

Explore the design features behind the proven performance of AirFit™ P10 and AirFit™ P10 for Her.

Slide to see all the design features

How AirFit™ P10 delivers performance

Explore the design features behind the proven performance of AirFit™ P10 and AirFit™ P10 for Her.

QuickFit™ headgear

Dual-wall silicone pillows

Lightweight flexi-tube

Simple, 3-part design

QuietAir™ venting (20 dBA⁶)

Slide to see all the design features

The benchmark for a reason

Proven mask performance. Provider trust. Over a decade in the making.

Buy now

References:

Source: Data are derived from an analysis of new PAP therapy patients in the United States using AirView™ and myAir™ platforms. Patients were included if myAir™ setup occurred from 7 days before through 14 days after the AirView™ setup date (i.e., −7 to +14 days) and valid mask data were available. Compliance (90-day) was assessed for setups between January 2024 and December 2024. Compliance was defined as PAP use for ≥4 hours per night on ≥70% of nights during any consecutive 30-day period within the first 90 days of therapy, with the AirView™ setup date counted as day 1. Days to compliance represents the number of days from AirView™ setup until the first date the patient achieved compliance. Analysis included the top 45 mask models, representing 99.8% of mask selections among new users in myAir™. Days to compliance (90th percentile) is the number of days from AirView™ setup by which 90% of patients achieved compliance. Overall average = 41.7 days mean across the 45 included mask models; n = 557,021. AirFit P10 = 39 days, n = 65,796.
Source: Based on an online, double-blinded survey of 92 U.S.-based HME providers conducted by Peel Research Partners, Dec 12–22, 2025.
Source: Data is derived from an analysis of new PAP therapy patients in the United States using AirView™ and myAir platforms. Patients were included if myAir™ setup occurred from 7 days before through 14 days after the AirView™ setup date (i.e., −7 to +14 days) and valid mask data were available. Compliance (90-day) was assessed for setups between January 2024 and December 2024. Compliance was defined as PAP use for ≥4 hours per night on ≥70% of nights during any consecutive 30-day period within the first 90 days of therapy, with the AirView setup date counted as day 1. Compliance Rate (%); AirFit™ P10 = 78.95%, n = 65,796.
Source: Leading nasal pillows masks selected based on Resmed analysis of U.S. market data as of June 2026. Masks reviewed: F&P Nova Micro, F&P Solo Pillows, Philips DreamWear Pillows, React Health Rio II, and AirFit P10. Comparison based on manufacturer-published user-guide sound power declarations and Resmed objective bench testing comparing AirFit P10 and F&P Nova Micro Pillows under flow-normalised conditions (approx. 33 L/min).
Source: Data are derived from an analysis of U.S. PAP therapy patients using AirView™ and myAir platforms. Patients were included based on registration within ±14 days of AirView setup and valid mask data. Compliance was assessed for 2024 setups (n = 557,021; AirFit™ P10 n = 65,796), and 1-year adherence for 2023 setups (n = 389,270; AirFit™ P10 n = 50,156). Compliance was defined as PAP use for ≥4 hours per night on ≥70% of nights during any consecutive 30-day period within the first 90 days of therapy. AirFit™ P10 demonstrated lower leak rates than the average for pillows masks (median 1.9 vs. 2.2 L/min; 95th percentile 12.0 vs. 12.7 L/min). No statistical significance testing was performed.
Source: Resmed internal verification testing conducted June 2026.